Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

But between shortages, high out of pocket costs and the need for weekly injections, the medication is not suited for everyone ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has reported that 68 people have been admitted to hospital ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

More than a quarter of us have learned all we know about weight-loss jabs through social media, so GP Dr Bryony Henderson has helped clear up the myths and misunderstandings ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

Semaglutide shows promise in treating knee osteoarthritis by reducing pain and weight, offering a safe alternative to ...

Tirzepatide, known under the brand name Mounjaro is prescribed for type 2 diabetes, but has been shown in clinical trials to ...

Nov 13 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of weekly injections. The results ...